Vaxart (VXRT) Surges as Influenza Study Published in Lancet
Tweet Send to a Friend
Vaxart, Inc. (NASDAQ: VXRT) is gaining 37% in pre-open trade after the company announced today that the results from its ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


